All stock reports

HEALTHX evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-10T14:01:38.361373+00:00

Metrics

latest_annual_period
2026-03-31
revenue
13076521000.0
net_income
11759000.0
operating_cash_flow
-738298000.0
free_cash_flow
-887613000.0
total_assets
9357687000.0
total_liabilities
1704970000.0
total_equity
6408881000.0
cash
301907000.0
total_debt
Not supplied
revenue_growth
0.20019768146025463
earnings_growth
-1.012898293353633
net_margin
0.0008992452962068428
roe
0.0018347976815297398
debt_to_equity
Not supplied
cash_conversion
-62.78578110383536
free_cash_flow_margin
-0.06787837529569218
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-e718ad64a16d5cebee2925e84db7efee1ee5dce5fd57db8916fd10fe4e052d21
Policy
stock-decisions-v1
Evidence bundle hash
571630fa48dd5f17404de999058e472f280237935e47b6ca38c90f96db830739
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 24556a697155585140bd0256ce0dcee5bb301c10fda40f9b4bd3b91e6314975f
  • daily-price: 6f9b5e77007cc12318333fba7f8bc716c880d7a85d35ba5953c0e82ca9e83fb1
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: VERIFIED. The cached closing price on 2026-10-01 was INR 273.00. The trailing 5-session price return was -6.07%. The trailing 20-session price return was -7.24%. The trailing 60-session price return was -13.24%. The trailing 250-session price return was -12.02%.

Risks

The closing price was -19.14% below its highest close in the available trailing year. The cached financial metric cash conversion is -62.78578110383536. Financial data check: balance_sheet_equation: difference=1243836000.00. Financial data check: weak_cash_conversion: operating cash flow/net income below 0.5. The cached financial metric free cash flow margin is -0.06787837529569218. The cached financial metric net margin is 0.0008992452962068428.

Follow Up

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.20019768146025463. Average cached traded value over twenty sessions was INR 1,696,622. Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-10T14:01:38.361373+00:00 from EODHD.

Cached observations and evidence limits